{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(2)"],"submitter":["Silang K"],"pubmed_abstract":["<h4>Background</h4>Preeclampsia affects between 2% and 5% of pregnant people in North America. First-trimester preeclampsia screening based on the Fetal Medicine Foundation risk calculation algorithm combined with treatment of high-risk patients with aspirin effectively reduces the incidence of preterm preeclampsia more than the currently used risk factor-based screening. However, the impact of such screening on patient satisfaction and maternal anxiety is unknown.<h4>Objective</h4>This study aimed to assess the impact of first-trimester prediction and prevention of preterm preeclampsia on patient satisfaction and anxiety.<h4>Study design</h4>Consenting pregnant patients participating in a local first-trimester (11-13+6 weeks) preterm preeclampsia screening and prevention implementation st"],"journal":["AJOG global reports"],"pagination":["100205"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10165256"],"repository":["biostudies-literature"],"pubmed_title":["First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety."],"pmcid":["PMC10165256"],"pubmed_authors":["Silang K","Pastuck M","Johnson JA","Maxey C","Tomfohr-Madsen L"],"additional_accession":[]},"is_claimable":false,"name":"First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety.","description":"<h4>Background</h4>Preeclampsia affects between 2% and 5% of pregnant people in North America. First-trimester preeclampsia screening based on the Fetal Medicine Foundation risk calculation algorithm combined with treatment of high-risk patients with aspirin effectively reduces the incidence of preterm preeclampsia more than the currently used risk factor-based screening. However, the impact of such screening on patient satisfaction and maternal anxiety is unknown.<h4>Objective</h4>This study aimed to assess the impact of first-trimester prediction and prevention of preterm preeclampsia on patient satisfaction and anxiety.<h4>Study design</h4>Consenting pregnant patients participating in a local first-trimester (11-13+6 weeks) preterm preeclampsia screening and prevention implementation st","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-18T15:13:16.58Z","creation":"2025-04-07T01:47:28.485Z"},"accession":"S-EPMC10165256","cross_references":{"pubmed":["37168545"],"doi":["10.1016/j.xagr.2023.100205"]}}